BIOMAT Database Logo BIOMAT Database Logo

Peripheral biomarkers for predicting sputum eosinophilia in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. 2023

Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
2nd Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.

UI MeSH Term Description Entries
D012120 Respiration Disorders Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available. Disorder, Respiration,Disorders, Respiration,Respiration Disorder
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
June 2019, Respiratory medicine,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
February 2021, The Journal of allergy and clinical immunology,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease.
March 2022, Allergy, asthma & immunology research,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Non-eosinophilic asthma in nonsteroidal anti-inflammatory drug exacerbated respiratory disease.
March 2023, Clinical and translational allergy,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management.
September 2023, Polish archives of internal medicine,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
May 2015, International forum of allergy & rhinology,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Hypersensitivity to intravenous succinate corticosteroids in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
January 2023, Frontiers in allergy,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab.
January 2017, The journal of allergy and clinical immunology. In practice,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
April 2017, Allergy,
Gabriela Trąd, and Marek Sanak, and Adam Ćmiel, and Natalia Celejewska-Wójcik, and Michał Czekaj, and Lucyna Mastalerz
Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.
January 2016, The journal of allergy and clinical immunology. In practice,
Copied contents to your clipboard!